Infectious Diseases News and Research

RSS

Collaborative study may lead to strategies to reduce antibiotic resistance

In a study that literally analyzed competing bacteria fighting it out to the death, a University of Houston (UH) researcher and his colleagues identified evolutionary 'winners' and 'losers.' Continuing research to understand the basis of these fates may become a useful tool is designing roadblocks to antibiotic resistance.

24 Mar 2011

Physicians launch international advocacy campaign on TB

Physicians across the globe are coming together to advocate for a large, underrepresented patient population - those suffering from tuberculosis. On World TB Day, March 24th, a team of physician and researchers led by Case Western Reserve University School of Medicine's Tuberculosis Research Unit will nationally launch "I am TB," an international advocacy campaign aimed at reducing stigma among patients with TB and those at risk for the disease.

24 Mar 2011

Strong 'innate immunity' effective in chikungunya patients

Chikungunya is transmitted by mosquitoes of the genus Aedes. The disease is spreading in the world and periodically sparks new outbreaks. Africa, Asia, the Indian Ocean and even Southern Europe are now affected.

23 Mar 2011

CMU's CNAST receives DSF Charitable Foundation grant to develop novel biomedical tools

The DSF Charitable Foundation has given a $3.9 million grant to Carnegie Mellon University's Center for Nucleic Acids Science and Technology to further the development of novel biomedical tools targeted at monitoring and manipulating gene expression.

22 Mar 2011

Researchers to develop house dust mite allergy vaccine that can cure asthma

Monash University researchers are working on a vaccine that could completely cure asthma brought on by house dust mite allergies.

22 Mar 2011

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

Insmed Incorporated, a biopharmaceutical company, announced today that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of ARIKACE™ (liposomal amikacin for inhalation) in nontuberculous mycobacteria (NTM) lung infections has been cleared by the U.S. Food and Drug Administration (FDA).

21 Mar 2011

APHA issues statement recommending improved safety for workers in adult film industry

In a newly posted position paper on its website, the American Public Health Association, the oldest and most diverse organization of public health professionals in the world representing over 50,000 health professionals and others who work to promote health, prevent disease and ensure conditions in which all can be safe and healthy, has issued a comprehensive policy statement, "Prevention and Control of Sexually Transmitted Infections and HIV among Performers in the Adult Film Industry," that includes a series of recommendations intended to foster improved safety and workplace conditions for workers in the adult film industry.

19 Mar 2011

Aid delivery trickles in one week after Japanese quake, tsunami

"Across large parts of Japan stricken a week ago by a quake and tsunami, aid isn't getting through. Blizzards, impassible roads, worries over radiation exposure, fuel shortages and other logistical problems have stalled aid from getting to those who need it, even as officials have boosted the amount of food and other goods available to some easier-to-reach communities," the Wall Street Journal reports.

19 Mar 2011

Study explores impact of electronic record systems on quality of care in developing countries

A new study, conducted by researchers from the Regenstrief Institute and the schools of medicine at Indiana University and Moi University, is one of the first to explore and demonstrate the impact of electronic record systems on quality of medical care in a developing country.

19 Mar 2011

CDC to award $2M grant to continue CARPE program in preventing healthcare-associated infections

The federal Centers for Disease Control and Prevention is awarding researchers at the Cook County Health & Hospitals System and Rush University Medical Center a $2 million grant to continue a successful program aimed at preventing healthcare-associated infections, antibiotic resistance, and other adverse events associated with healthcare.

19 Mar 2011

Quest Diagnostics enters definitive merger agreement to acquire Celera for $8 per share

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, and Celera Corporation, one of the world's pioneers in genetic diagnostics discovery and development, announced today that they have entered into a definitive merger agreement under which Quest Diagnostics will acquire Celera for $8 per share, representing a transaction value of approximately $344 million, net of $327 million in acquired cash and short-term investments.

From Quest Diagnostics 18 Mar 2011

Study sheds light on how vitamin A contributes to immune responses in gastrointestinal tract

Although it has been known for some time that vitamin A deficiency is linked with an impaired ability to resist infections, exactly how vitamin A and its metabolites contribute to the immune response is not well understood.

18 Mar 2011

Wash your hands? You may now approach the patient bed!

Each year patients in the U.S. get more than a million infections while in the hospital being treated for something else. The best way to prevent infection is to practice proper hand hygiene, according to the U.S. Centers for Disease Control and Prevention.

17 Mar 2011

Harvard, UCI receive $2 million CDC grant to help reduce hospital-borne MRSA infections

A UC Irvine infectious disease specialist will be part of a nationwide Centers for Disease Control and Prevention research program to develop and test innovative approaches to reducing infection in healthcare settings.

17 Mar 2011

Inovio signs agreement with OncoSec to sell non-DNA cancer vaccine technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has signed an agreement with OncoSec Medical Inc. providing for the sale to OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.

17 Mar 2011

Research highlights new parameters for HIV study

A research article co-authored by Brenna Anderson, MD, director of Reproductive Infectious Diseases Consultation in the Division of Maternal-Fetal Medicine at Women & Infants Hospital of Rhode Island, was included in the recently published special issue of the American Journal of Reproductive Immunology.

17 Mar 2011

Experts to discuss work directions for fight against TB at ITM conference in Antwerp

On occasion of the World TB Day, leading experts from 12 countries will take stock of the fight against tuberculosis, during a conference at the Institute of Tropical Medicine in Antwerp.

17 Mar 2011

Ambry, LABS partner to offer new donor and patient screening options

LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry Genetics, a global leader in molecular diagnostics and genomic services to the healthcare and life sciences industries, that will allow the organizations to provide superior testing services to a broader base of clients in the reproductive health industry.

16 Mar 2011

iTherX commences ITX-5061 Phase 1b study in patients with HCV

iTherX, a pharmaceutical company dedicated to discovering and developing a new class of therapies for hepatitis C, today announced that it has commenced patient recruitment in an open-label, proof-of-concept Phase 1b study of its lead compound ITX-5061 in liver transplant patients with hepatitis C virus infection.

16 Mar 2011

Elevated p21 expression may block key steps in viral life cycle

Elevated levels of p21, a protein best known as a cancer fighter, may be involved in the ability of a few individuals to control HIV infection with their immune system alone.

15 Mar 2011

Infectious Diseases News and Research

Collaborative study may lead to strategies to reduce antibiotic resistance

Physicians launch international advocacy campaign on TB

Strong 'innate immunity' effective in chikungunya patients

CMU's CNAST receives DSF Charitable Foundation grant to develop novel biomedical tools

Researchers to develop house dust mite allergy vaccine that can cure asthma

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

APHA issues statement recommending improved safety for workers in adult film industry

Aid delivery trickles in one week after Japanese quake, tsunami

Study explores impact of electronic record systems on quality of care in developing countries

CDC to award $2M grant to continue CARPE program in preventing healthcare-associated infections

Quest Diagnostics enters definitive merger agreement to acquire Celera for $8 per share

Study sheds light on how vitamin A contributes to immune responses in gastrointestinal tract

Wash your hands? You may now approach the patient bed!

Harvard, UCI receive $2 million CDC grant to help reduce hospital-borne MRSA infections

Inovio signs agreement with OncoSec to sell non-DNA cancer vaccine technology

Research highlights new parameters for HIV study

Experts to discuss work directions for fight against TB at ITM conference in Antwerp

Ambry, LABS partner to offer new donor and patient screening options

iTherX commences ITX-5061 Phase 1b study in patients with HCV

Elevated p21 expression may block key steps in viral life cycle

Industry Focus: Infectious Diseases eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News